
Lucata Corporation revolutionizes graph analytics and machine learning with its next-generation computing architecture, leveraging patented migrating thread technology to enable organizations to perform high-performance, multi-hop analytics on massive datasets without the limitations of traditional computing. Their solutions allow for real-time analysis of unpruned and unsharded databases, supporting industries such as financial services, cybersecurity, and healthcare. With a focus on scalability and efficiency, Lucata's technology significantly reduces power consumption and physical space requirements compared to conventional systems, positioning the company as a leader in advanced analytics and AI solutions.

Lucata Corporation revolutionizes graph analytics and machine learning with its next-generation computing architecture, leveraging patented migrating thread technology to enable organizations to perform high-performance, multi-hop analytics on massive datasets without the limitations of traditional computing. Their solutions allow for real-time analysis of unpruned and unsharded databases, supporting industries such as financial services, cybersecurity, and healthcare. With a focus on scalability and efficiency, Lucata's technology significantly reduces power consumption and physical space requirements compared to conventional systems, positioning the company as a leader in advanced analytics and AI solutions.
What they do: Develop a migrating-thread computing architecture for high-performance graph analytics and unified-memory AI/ML workloads
Headquarters: New York, New York, United States
Founders: Peter M. Kogge; Jay Brockman; Ed Upchurch
Employee count (reported): 8
Recent disclosed funding: Series B $11.9M (Jul 2021) and grants; total disclosed funding $29,240,000
Memory-limited scaling for graph analytics and AI/ML workloads
High-performance computing; AI/ML infrastructure; Graph analytics
11,900,000.00
Reported Series B of $11.9M in July 2021
Grant funding disclosed with NSF listed as lead
“Has received grant support (National Science Foundation) and reported investors include Maulick Capital, Samsung Ventures, Varian Medical Systems, and Middleburg Capital Development”